ISSN:
1546-1696
Source:
Nature Archives 1869 - 2009
Topics:
Biology
,
Process Engineering, Biotechnology, Nutrition Technology
Notes:
[Auszug] To the editor: Interest in oligonucleotide antisense therapeutics has regained momentum. One antisense therapeutic, Vitravene, has been approved, 12 are in clinical trials, and others are in various planning stages. High-quality chemical synthesis of antisense oligonucleotides via nucleobase and ...
Type of Medium:
Electronic Resource
URL:
http://dx.doi.org/10.1038/nbt0902-871b
Permalink